Graziela Domingues de Almeida Lima

2PUBLICATIONS
8CO-AUTHORS
ChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Feb 15, 2025
HDAC6 inhibition through WT161 synergizes with temozolomide, induces apoptosis, reduces cell motility, and decreases β-catenin levels in glioblastoma cells.

Leilane Sales Oliveira, João Marcos Oliveira-Silva, Hebreia Oliveira Almeida-Souza

|Jan 17, 2025
WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells.

João Marcos Oliveira-Silva, Leilane Sales Oliveira, Carolina Berraut Chiminazo

Pageof 1

Frequent Collaborators

2 joint publications

Alexandre Ferro Aissa

2 joint publications

Marisa Ionta

2 joint publications

Angel Mauricio Castro-Gamero

1 joint publications

João Marcos Oliveira-Silva

1 joint publications

Carlos Vinicius Expedito de Souza

1 joint publications

Hebreia Oliveira Almeida-Souza

1 joint publications

Mario Machado Martins

1 joint publications

Luciana Machado Bastos

Frequent Collaborators

2 joint publications

Alexandre Ferro Aissa

2 joint publications

Marisa Ionta

2 joint publications

Angel Mauricio Castro-Gamero

1 joint publications

João Marcos Oliveira-Silva

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on : Mar 28, 2021

2.7K
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on : Aug 10, 2017

8.5K
See more related videos

Top Related Videos

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on : Mar 28, 2021

2.7K
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on : Aug 10, 2017

8.5K
See more related videos